Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.570
-0.090 (-5.42%)
At close: Aug 1, 2025, 4:00 PM
1.640
+0.070 (4.46%)
After-hours: Aug 1, 2025, 6:45 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $89.52 million as of August 1, 2025. Its market cap has decreased by -53.18% in one year.
Market Cap
89.52M
Enterprise Value
61.59M
1-Year Change
-53.18%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $89.52M, a decrease of -81.69%. That is a compound annual growth rate of -32.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 89.52M | -36.33% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | 489.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |